Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03130335 · ClinicalTrials.gov registry record · NA
Intra-articular Autologous Bone Marrow Aspirate Injection for Knee Osteoarthritis
A NA study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT03130335 is a NA study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 13 participants.
The verdict
NCT03130335, a NA study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
Knee osteoarthritis (OA) is a leading cause of disability. The objectives of treatment are to reduce pain, improve function, and slow down further breakdown of the knee. Recently, research on nonsurgical treatment options for knee OA has increased significantly. One potential treatment of interest is the use of stem cell injections. Stem cells are one's own cells that have the ability to divide into other types of cells, and may cause regrowth of cartilage when injected into the knee. There have been few, but promising, studies that show improvements in pain and function with stem cell injections in those with knee OA. Therefore, more research is needed to identify patients who might benefit from this injection. This pilot study will look at changes in pain and function for 20 patients at 1, 3, 6, and 12 months after a stem cell injection into the knee. Patients will also undergo magnetic resonance imaging at 6 months and 12 months following the injection.
Interventions
- PROCEDURE BMA Injection
- BIOLOGICAL BMA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2017-04-28 |
| Est. Completion | 2019-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03130335
The ClinicalTrials.gov registry entry for NCT03130335 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BMA Injection is the first listed.
NCT03130335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03130335 about?
NCT03130335 is a clinical study titled "Intra-articular Autologous Bone Marrow Aspirate Injection for Knee Osteoarthritis". Knee osteoarthritis (OA) is a leading cause of disability. The objectives of treatment are to reduce pain, improve function, and slow down further breakdown of the knee. Recently, research on nonsurgical treatment options for knee OA has increased significantly. One potential treatment of interest i...
What is the current status of trial NCT03130335?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2017-04-28. Estimated completion is 2019-10-01.
What interventions are being tested in trial NCT03130335?
The interventions under investigation include: BMA Injection (PROCEDURE), BMA (BIOLOGICAL).
Who is sponsoring clinical trial NCT03130335?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.